Trial intelligence / Profile preview

Cardiometry vs FACTT Lite for Fluid Management in ARDS

NCT04219150Completed

Sponsor
Tanta University
Start
Jan 2020
Primary completion
Feb 2021
Countries
1
01

Overview

Randomised, open-label trial in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Tanta University. Primary endpoint: Percentage of mortality at 28th day at 28 days. Started Jan 2020; status: completed.

02

Conditions

acute respiratory distress syndrome (ARDS)

Beyond the preview

Go deeper on NCT04219150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04219150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call